drugset / Trial / NCT04871724

Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects

NCT04871724

Phase 1 Completed 24 enrolled Enanta Pharmaceuticals, Inc
NaSingle-groupOpen-labelTreatment

Summary

A Non-Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics and Safety of EDP-938 in Healthy Subjects

Timeline

Start
2021-03-12
Primary completion
2021-03-30
Completion
2021-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule
Subject zelicapavir Small molecule